Clinical Trial Update: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial update showing completion and posted results for subcutaneous Mircera given monthly to treat anemia in adults with chronic kidney disease not on d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Renal Anemia, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2016-11-01